Yee-Ping Ho
Affiliations: | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
Medical Biophysics, Pharmacy, Pharmaceutical Chemistry, Physical ChemistryGoogle:
"Yee-Ping Ho"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pang SK, So WK, Ho YP, et al. (2014) East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes. Anti-Cancer Agents in Medicinal Chemistry. 14: 756-61 |
| Pang SK, Yu CW, Guan H, et al. (2008) Impact of oxaliplatin and a novel DACH-platinum complex in the gene expression of HCT116 colon cancer cells. Oncology Reports. 20: 1269-76 |
| Pang SK, Yu CW, Au-Yeung SC, et al. (2007) DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes. Biochemical and Biophysical Research Communications. 363: 235-40 |
| Wang X, Au-Yeung SC, Ho YP. (2007) Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats. Journal of Inorganic Biochemistry. 101: 909-17 |
| To KK, Au-Yeung SC, Ho YP. (2006) Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles. Anti-Cancer Drugs. 17: 673-83 |
| Yu CW, Li KK, Pang SK, et al. (2006) Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane. Bioorganic & Medicinal Chemistry Letters. 16: 1686-91 |
| To KK, Ho YP, Au-Yeung SC. (2005) In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents. Anti-Cancer Drugs. 16: 825-35 |
| To KK, Ho YP, Au-Yeung SC. (2005) Synergistic interaction between platinum-based antitumor agents and demethylcantharidin. Cancer Letters. 223: 227-37 |
| To KK, Wang X, Yu CW, et al. (2004) Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. Bioorganic & Medicinal Chemistry. 12: 4565-73 |
| Ho YP, Au-Yeung SC, To KK. (2003) Platinum-based anticancer agents: innovative design strategies and biological perspectives. Medicinal Research Reviews. 23: 633-55 |